Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001826466-24-000068
Filing Date
2024-05-28
Accepted
2024-05-28 17:12:53
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 269215
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7068
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3229
  Complete submission text file 0001826466-24-000068.txt   1889149

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nika-20240331.xsd EX-101.SCH 17762
5 XBRL CALCULATION FILE nika-20240331_cal.xml EX-101.CAL 23605
6 XBRL DEFINITION FILE nika-20240331_def.xml EX-101.DEF 74552
7 XBRL LABEL FILE nika-20240331_lab.xml EX-101.LAB 150545
8 XBRL PRESENTATION FILE nika-20240331_pre.xml EX-101.PRE 135040
46 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 143984
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

IRS No.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56234 | Film No.: 24992980
SIC: 3790 Miscellaneous Transportation Equipment
(CF Office: 04 Manufacturing)